Toei Animation4816.T
Licensing prints a 55.1% segment operating margin and 73.1% of segment operating profit at FY March 2026, on a net-cash balance sheet and 24.5% ex-cash ROIC. The forward P/E of 17.3x reads cheap against a five-year mean of 32.8x contaminated by the 2020–21 content bubble; against the out-of-bubble anchor of 18–20x it reads at fair value. After normalising the yen, SOTP fair value reconstructs to ¥1,950–2,100; spot is ¥2,366. The thesis is a position on the persistence of a weak yen.
Licensing at ¥23.2bn of FX-normalised operating profit, valued as a perpetual rent at 13.5x, is approximately ¥313bn of segment enterprise value.
Film at ¥8.5bn cyclical AOP at 8x adds ¥68bn; corporate adjustment capitalised at −¥66bn; goods and others marginal. Gross enterprise value reconstructs to ¥322bn.
Net cash of ¥93bn bridges enterprise value to ¥415bn of equity, or ¥1,975 per share on 210m shares.
Spot market cap is ¥496.9bn at ¥2,366. The market is paying a 15–20% premium to FX-normalised intrinsic value.
The dossier rests on one decomposition. The licensing rent carries 73.1% of segment operating profit at a 55.1% margin on a net-cash balance sheet. The question is whether the organic ex-FX growth of that rent justifies a quality premium, or whether the consolidated 33.1% EBIT margin is a partly monetary peak that normalises as the yen reverts. The fair-value dispersion is almost entirely a dispersion of the normative USD-JPY applied. The licensing margin and the multiple are second-order to it.
The consensus reads the recent margin record as evidence of a content compounder and prices a top-line recovery — consensus estimates revenue of ¥103bn and ¥116bn for FY March 2027 and 2028 against ¥93.7bn delivered. The forward P/E of 17.3x against a five-year mean of 32.8x is read as a discount.
The variant decomposes the licensing margin into a structural component, observable as a 45%→55% expansion across ten years of paced operating leverage, and a yen-translation component carried by the ~64% overseas revenue share at a near-historical-low yen. The five-year multiple mean is contaminated by the 2020–21 content bubble, where the close P/E reached 43.8x. Against the out-of-bubble anchor of 18–20x, the 17.3x forward is fair value. The apparent discount sits in the bubble-contaminated denominator.
The SOTP reconstructed at a ¥140 normative USD-JPY delivers ¥1,950–2,100 per share against spot at ¥2,366. The weighted fair value across the three scenarios is ¥2,065, a −12.7% asymmetry. The upside case requires the yen to hold near ¥155 and idle capital to be returned — neither carries a dated catalyst.
Position framing is monitoring at current levels. Sizing is 0%. Conviction is moderate. The diagnostic prints are the ex-FX licensing royalty growth at FY March 2027 and the USD-JPY level; a buyback or a payout above 50% would requalify the dossier toward LONG.
The window from FY March 2016 to FY March 2026 reads as three sequential regimes. Rent emergence through FY March 2019, with the licensing segment scaling overseas and EBIT margin lifting from 22.7% to 28.3%. COVID trough and the first yen tailwind from FY March 2020 to 2022, with Film at a standstill, a sectoral multiple bubble, and the close P/E reaching 43.8x. Franchise super-cycle and derating from FY March 2023 to 2026, with One Piece Film Red and Dragon Ball Super Super Hero plus a structurally weak yen pushing revenue to a ¥100.8bn peak while the multiple compressed from the bubble toward 17–21x.
| Inflection | FY Mar 2016Rent emerging | FY Mar 2019Overseas scaling | FY Mar 2021COVID trough | FY Mar 2023Franchise peak | FY Mar 2026Peak FX · derating |
|---|---|---|---|---|---|
| Revenue (¥bn) | 33.6 | 55.7 | 51.6 | 87.5 | 93.7 |
| EBIT (¥bn) | 7.6 | 15.7 | 15.5 | 28.7 | 31.0 |
| EBIT margin | 22.7% | 28.3% | 30.0% | 32.8% | 33.1% |
| Licensing OP (¥bn) | 6.2 | 14.4 | 14.3 | 20.9 | 26.7 |
| Licensing margin | 45.1% | 47.8% | 49.3% | 49.9% | 55.1% |
| FCF (¥bn) | 4.6 | 10.5 | 8.0 | 15.1 | 16.2 |
| Net cash (¥bn) | 19.4 | 34.3 | ~55 | ~70 | 92.9 |
| EPS (¥, split-adjusted) | ~12 | ~54 | 54.1 | 102.2 | 122.7 |
Source: Data pack and Excel Segments/Ratios/Cash Flow, pull 29 May 2026. FY March 2026 = year ended 31 March 2026. EPS split-adjusted for the 1-for-5 of March 2024 and 1-for-3 of March 2018. Net cash for FY March 2021 and 2023 reconstructed from net-debt/EBITDA triangulation; reported values approximate.
Net cash rose from ¥19.4bn to ¥92.9bn over the same window while the payout ratio moved only from 24.8% to 36.2% and no buyback was executed. Reported ROE fell from 19.9% to 15.5% as the cash pile diluted return on total capital, even as ex-cash ROIC held near 24.5%. The Management pillar at 2.5/5 captures this directly.
The engine is a binary of a compounding licensing rent grafted onto a cyclical Film operation. Licensing carries 51.7% of revenue and 73.1% of segment operating profit at a 55.1% margin; Film carries 33.2% of revenue for 23.9% of segment operating profit at a margin that has run 15–29% across the decade. The royalty monetises an evergreen catalogue at near-zero marginal cost, capex below 1% of revenue. Value is created in the rent.
The demand vector is the international penetration of the catalogue, observable as the overseas revenue share rising from 42.8% at FY March 2018 to 63.7% at FY March 2026. That share is structural and decorrelated from the Film release calendar — North America 23%, Asia 20%, Europe 17%. The Film cycle is calendar-driven, with One Piece Film Red and Dragon Ball Super Super Hero producing the +53% revenue year at FY March 2023.
The critical input is not a commodity. The cost base is talent and intellectual property, so there is no freight, tariff or raw-material shock to absorb. The single structural cost-and-risk variable is the renewal and defence of the franchises, a discretionary and intangible spend with a deferred effect — underinvestment erodes the rent over five to ten years without a contemporaneous P&L signal. The observable line diluting segment operating profit is the corporate adjustment at −¥5.5bn, up steadily from −¥1.9bn at FY March 2016.
FCF conversion is high but lumpy. FCF/EBIT ran 53%, 69%, 82% and 52% across the four years to FY March 2026, as the overseas receivables lengthened the cash conversion cycle and days sales outstanding ran near 100. The yen is the single swing variable of the valuation. Overseas revenue of ~¥59.7bn at a ~12% yen appreciation toward the ¥140 mid-cycle removes ~¥7bn of translated revenue, roughly 70–75% in margin, for a ~¥4–5bn AOP haircut — from ¥31bn reported to ~¥27bn normalised. The FX adjustment is the only material retreatment; every other line is clean. That cleanliness concentrates the entire valuation risk on one exogenous variable.
Asset-light with capex below 1% of revenue at ¥778m on ¥93.7bn. Ex-cash ROIC near 24.5% sits roughly 18 points above WACC, and the licensing margin has expanded from 45% to 55% across ten years through operating leverage rather than a single FX year. The drag is the cash pile: reported ROE of 15.5% against ex-cash ROIC of 24.5% measures the dilution, and FCF conversion is lumpy. Far above Kadokawa at 3.3% ROIC below WACC and above Toho's 4.6% book-yield real estate.
Operational execution is strong; capital allocation is the weakness. Net cash compounded five-fold to ¥92.9bn over ten years with no buyback and a payout capped at 36.2%, sterilising 18.7% of the market cap under a TSE regime that penalises idle capital. A decade of cumulative FCF has not been converted into catalogue diversification, leaving the ~73% operating-profit concentration on two franchises unresolved. This pillar is why the rent does not re-rate.
Recurring royalty on an evergreen catalogue; overseas share 43%→64% structural; licensing OP resilient at +3.1% in a down year. Capped by two-franchise concentration and FX exposure.
Catalogue owned at Level 1 of the chain, irreplaceable, with high licensee switching costs and a 55% margin defended over ten years. Exposed to platform disintermediation on royalty rates and to the concentration.
Payout rising 24.8%→36.2% but still low for a net-cash issuer with no capital need; zero buyback under TSE pressure. The capital link with Toei Company (9605) as reference shareholder remains to be clarified.
A radical dissociation between operational quality (model 4.5, moat 4.0, demand 4.0) and capital quality (management 2.5, governance 2.5). Comparable to Toho at 17.0/25 on a different engine, far above Kadokawa at 10.5/25. The grade supports a quality premium on the operating engine. It does not support a buy at the current price once the yen is normalised.
Is the licensing rent a structural compounder or an FX-flattered peak ?
Is the P/E discount real or an out-of-bubble re-anchoring ?
The 17.3x forward against a 32.8x five-year mean reads as a deep discount. The five-year mean embeds the 2020–21 bubble, where the close P/E reached 43.8x. Recalculated out of bubble, the normative anchor is 18–20x P/E and 9–12x EV/EBITDA; the spot 12.7x ex-cash EV/EBITDA sits above the pre-bubble normal. Sub-industry Market Rule 2 — an FX-flattered earnings base is not durably capitalised — applies to the overseas-heavy engine.
Is idle capital a TSE re-rating option or chronic sterilisation ?
Net cash of ¥92.9bn is 18.7% of the market cap at a 36.2% payout. A buyback under TSE pressure would mechanically lift the ROE from 15.5% toward the 24.5% ex-cash ROIC and unlock a re-rating. The payout has risen 24.8%→36.2% while net cash compounded five-fold — the option exists with no execution record.
At ¥2,366 spot and 17.3x forward P/E, the market is pricing a content-cycle recovery on FX-flattered earnings. Two implicit choices do the work. The yen is treated as durable at the near-low ¥159 USD-JPY, with no material normalisation discount applied to translated royalty. The licensing margin is read as the base of a compounder rather than a partly monetary peak. The cellular SOTP at a ¥140 normative yen reconstructs equity value at ¥415bn, or ¥1,975 per share, a 15–20% premium to spot. Price-to-book at 2.83x and the reported EV/EBITDA are rejected as anchors — the value is in an intangible rent, not the balance sheet.
The yen firms toward ¥125–130 as the rate differential closes, amputating the overseas royalty. A year without a catalyst franchise compresses Film, and the market applies a concentration discount to the two-franchise dependence. Licensing AOP normalises to ¥21.5bn, Film to a ¥5bn trough, multiples compress to 11x and 6x. The downside is a timing disappointment, reversible, with the floor anchored on net cash of ¥443 per share plus residual rent value.
The rent holds at flat-to-slightly-positive ex-FX growth, Film returns to mid-cycle, the yen appreciates moderately toward ¥140, and management does not return the cash. The consolidated margin reflows toward 30–31% FX-normalised. The SOTP at 13.5x licensing and 8x Film delivers ¥1,950–2,100. Consolidated re-rating happens or does not; the fair value does not require it.
The yen holds structurally weak near ¥155, preserving the translated royalty; a new franchise or a major streaming catalyst emerges; and management announces a material buyback under TSE pressure, lifting the ROE and re-rating the multiple. Licensing AOP holds ¥31–33bn, multiples expand to 16x and 9x. Three triggers in sequence over 18–24 months.
| KPI | Latest value | Status | What it tells us |
|---|---|---|---|
| Ex-FX licensing royalty growth | ~flat (FY26) | Cardinal | The number governing Debate 1. Disclosed at FY March 2027. Positive ex-FX growth validates the structural compounder; negative over two years reclassifies toward an exporter value trap (Thesis Breaker T3). |
| USD-JPY level | ~159 | Asymmetric | Near-historical-low, range 142–161. The single swing variable of fair value. Below ¥135 sustained moves fair value toward the floor (bear); above ¥155 held supports the bull (Thesis Breaker T1). |
| Licensing segment margin | 55.1% (FY26) | Holding | +3.1% OP growth in a down revenue year. The structural component of the engine. The line that proves the rent is not a pure FX or Film artefact. |
| EV/AOP consolidated multiple | ~13x | Watch | Above 15x signals a re-rating toward LONG; below 11x signals a de-rating toward the floor (Thesis Breaker T2). |
| Buyback or payout >50% | none | Trigger | Bull-confirmation. A material buyback by the FY March 2027 AGM lifts ROE toward 24.5% ex-cash ROIC and confirms the shareholder-alignment option. |
| Net cash / market cap | 18.7% | Holding | ¥92.9bn, zero debt. The patrimonial floor at ¥443 per share. Sterilised idle capital diluting reported ROE. |
| Reported ROE vs ex-cash ROIC | 15.5% / 24.5% | Reference | The gap measures the allocation drag. Closure requires capital return, not operating improvement. |
| FCF yield (spot / normalised) | 3.3% / ~4.5% | Reference | Barely covers the 7–8% cost of equity on a dividend-only shareholder yield of 1.86%. The floor is patrimonial. |
| Beta brut | 0.20 | Reference | Near-zero market correlation. Demand tracks catalogue penetration and the yen. |
A material buyback above 5% of capital or a payout lifted above 50% by the FY March 2027 AGM would unlock the ROE and requalify the dossier toward LONG. A USD-JPY held above ¥155 across FY March 2027 would preserve the translated royalty and shift the weighted asymmetry toward neutral. The emergence of a third world-scale franchise would reduce the two-franchise concentration and lift the demand pillar.
Ex-FX licensing royalty growth negative across two consecutive years, absent a new franchise at the pipeline, reclassifies the rent from compounder to exporter value trap and confirms the bear. A USD-JPY firming below ¥135 amputates the overseas royalty mechanically and moves fair value toward the ¥1,450–1,525 floor.
A structural multi-year decline in the ex-FX royalty of One Piece or Dragon Ball, or durable platform disintermediation of royalty rates, would break the rent itself and remove the floor — the only path to permanent loss rather than timing disappointment. This forces a full cellular re-underwriting that this initiation does not attempt. Currently not signalled.
The information provided on this website is for informational and educational purposes only and should not be construed as financial, investment, legal, or tax advice. All content reflects the personal opinions, interpretations, and analyses of the author at the time of writing and is subject to change without notice. Nothing contained herein constitutes, or should be interpreted as, a recommendation, solicitation, or offer to buy or sell any securities, financial instruments, or other investment products. The author is not a licensed financial advisor, broker, or investment professional. Any references to specific assets, markets, or strategies are illustrative in nature and do not constitute personalized investment advice. Investing in financial markets involves risk, including the potential loss of capital. Past performance is not indicative of future results. Readers are solely responsible for their own investment decisions and should conduct their own independent research and due diligence before making any financial commitments. You are strongly encouraged to consult with a qualified financial advisor, legal professional, or other relevant specialist before making any investment or financial decisions. By accessing and using this blog, you agree that the author shall not be held liable for any direct or indirect losses, damages, or consequences arising from the use of, or reliance on, the information presented herein. All content is provided "as is" without any warranties of completeness, accuracy, or reliability.